Vertex Pharmaceuticals (VRTX) Short Interest Ratio & Short Volume → Elon Musk’s chilling warning for humanity (From The Freeport Society) (Ad) Free VRTX Stock Alerts $479.35 +3.56 (+0.75%) (As of 12:16 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Vertex Pharmaceuticals Short Interest DataCurrent Short Interest4,350,000 sharesPrevious Short Interest3,770,000 sharesChange Vs. Previous Month+15.38%Dollar Volume Sold Short$1.98 billionShort Interest Ratio4.0 Days to CoverLast Record DateMay 31, 2024Outstanding Shares258,050,000 sharesFloat Size257,360,000 sharesShort Percent of Float1.69%Today's Trading Volume240,321 sharesAverage Trading Volume1,214,984 sharesToday's Volume Vs. Average20% Short Selling Vertex Pharmaceuticals ? Sign up to receive the latest short interest report for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVRTX Short Interest Over TimeVRTX Days to Cover Over TimeVRTX Percentage of Float Shorted Over Time Ad The Freeport SocietyElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.Go here to see why. Vertex Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20244,350,000 shares $1.98 billion +15.4%1.7%4 $455.34 5/15/20243,770,000 shares $1.65 billion -2.6%1.5%3.6 $437.49 4/30/20243,870,000 shares $1.52 billion -4.0%1.5%3.7 $392.81 4/15/20244,030,000 shares $1.60 billion +1.3%1.6%3.3 $397.36 3/31/20243,980,000 shares $1.66 billion -3.6%1.6%3.1 $418.01 3/15/20244,130,000 shares $1.68 billion +2.0%1.6%3.3 $407.69 Get the Latest News and Ratings for VRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/29/20244,050,000 shares $1.70 billion -1.9%1.6%2.8 $420.74 2/15/20244,130,000 shares $1.76 billion +24.8%1.6%2.8 $426.29 1/31/20243,310,000 shares $1.43 billion -1.2%1.3%2.1 $433.38 1/15/20243,350,000 shares $1.45 billion +2.8%1.3%2.3 $433.40 12/31/20233,260,000 shares $1.33 billion -8.2%1.3%2.3 $406.89 12/15/20233,550,000 shares $1.46 billion +32.0%1.4%2.5 $410.68 11/30/20232,690,000 shares $954.44 million +7.2%1.1%2.2 $354.81 11/15/20232,510,000 shares $876.84 million -3.5%1.0%2.2 $349.34 10/31/20232,600,000 shares $941.49 million -9.1%1.0%2.6 $362.11 10/15/20232,860,000 shares $1.06 billion +0.4%1.1%2.9 $371.00 9/30/20232,850,000 shares $991.06 million -0.4%1.1%2.9 $347.74 9/15/20232,860,000 shares $997.85 million -2.1%1.1%2.9 $348.90 8/31/20232,920,000 shares $1.02 billion +7.0%1.1%2.7 $348.34 8/15/20232,730,000 shares $954.90 million -4.6%1.1%2.2 $349.78 7/31/20232,860,000 shares $1.01 billion +13.9%1.1%2.3 $352.34 7/15/20232,510,000 shares $885.38 million -8.1%1.0%1.9 $352.74 6/30/20232,730,000 shares $960.71 million No Change1.1%2.2 $351.91 6/15/20232,730,000 shares $952.99 million -11.1%1.1%2.2 $349.08 5/31/20233,070,000 shares $993.36 million -5.0%1.2%2.6 $323.57 5/15/20233,230,000 shares $1.13 billion -0.3%1.3%3 $348.65 4/30/20233,240,000 shares $1.10 billion -4.1%1.3%2.9 $340.73 4/15/20233,380,000 shares $1.13 billion -3.4%1.3%2.9 $333.52 3/31/20233,500,000 shares $1.10 billion +19.9%1.4%2.8 $315.07 3/15/20232,920,000 shares $859.27 million +9.0%1.1%2.3 $294.27 2/28/20232,680,000 shares $777.98 million -4.3%1.1%2.1 $290.29 2/15/20232,800,000 shares $836.50 million -11.1%1.1%2 $298.75 1/31/20233,150,000 shares $1.02 billion +19.8%1.2%2.2 $323.10 1/15/20232,630,000 shares $791.47 million +5.2%1.0%1.8 $300.94 12/30/20222,500,000 shares $721.95 million -19.1%1.0%1.8 $288.78 12/15/20223,090,000 shares $952.96 million +10.0%1.2%2.1 $308.40 11/30/20222,810,000 shares $889.08 million -7.3%1.1%1.9 $316.40 11/15/20223,030,000 shares $925.00 million +6.7%1.2%2.2 $305.28 10/31/20222,840,000 shares $886.08 million -3.1%1.1%2.1 $312.00 10/15/20222,930,000 shares $859.11 million -5.8%1.2%2.2 $293.21Gold Prices Surge and This $0.32 Stock Is Reaping The Rewards (Ad)Gold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially for a $0.32 gold producer that's flying under the radar.Here's what you need to know about this $0.32 gold producer. 9/30/20223,110,000 shares $900.47 million +7.6%1.2%2.3 $289.54 9/15/20222,890,000 shares $831.37 million +2.1%1.1%2 $287.67 8/31/20222,830,000 shares $797.38 million +10.1%1.1%1.9 $281.76 8/15/20222,570,000 shares $785.21 million -24.9%1.0%1.6 $305.53 7/31/20223,420,000 shares $959.00 million -4.7%1.3%2 $280.41 7/15/20223,590,000 shares $1.05 billion +14.0%1.4%2.1 $292.84 6/30/20223,150,000 shares $887.64 million -7.9%1.2%1.8 $281.79 6/15/20223,420,000 shares $867.00 million -10.9%1.3%1.9 $253.51 5/31/20223,840,000 shares $1.03 billion +7.3%1.5%2.3 $268.65 5/15/20223,580,000 shares $883.26 million +5.0%1.4%2.2 $246.72 4/30/20223,410,000 shares $931.68 million -16.8%1.4%2.1 $273.22 4/15/20224,100,000 shares $1.18 billion +2.2%1.6%2.4 $287.97 3/31/20224,010,000 shares $1.05 billion +19.4%1.6%2.3 $260.97 3/15/20223,360,000 shares $829.89 million -6.4%1.3%2 $246.99 2/28/20223,590,000 shares $825.77 million +10.1%1.4%2.1 $230.02 2/15/20223,260,000 shares $760.92 million +8.7%1.3%1.7 $233.41 1/31/20223,000,000 shares $729.15 million -1.3%1.2%1.5 $243.05 1/15/20223,040,000 shares $711.54 million +4.5%1.2%1.6 $234.06 12/31/20212,910,000 shares $639.04 million -9.4%N/A0 $219.60 12/15/20213,210,000 shares $677.73 million +12.6%1.3%1.7 $211.13 11/30/20212,850,000 shares $532.78 million -1.7%1.1%1.6 $186.94 11/15/20212,900,000 shares $541.89 million -39.1%1.2%1.9 $186.86 10/29/20214,760,000 shares $880.27 million +7.2%1.9%2.9 $184.93 10/15/20214,440,000 shares $807.06 million -12.4%1.7%2.7 $181.77 9/30/20215,070,000 shares $919.65 million +2.2%2.0%2.8 $181.39 9/15/20214,960,000 shares $936.75 million +2.7%1.9%2.5 $188.86 8/31/20214,830,000 shares $967.40 million -4.2%1.9%2 $200.29 8/13/20215,040,000 shares $979.57 million +20.3%2.0%2.1 $194.36 7/30/20214,190,000 shares $844.62 million +2.4%1.6%1.8 $201.58 7/15/20214,090,000 shares $818.37 million +0.5%1.6%1.9 $200.09 6/30/20214,070,000 shares $820.63 million -10.0%1.6%1.9 $201.63 6/15/20214,520,000 shares $854.14 million +11.6%1.8%2.3 $188.97 5/28/20214,050,000 shares $844.95 million -1.5%1.6%2.5 $208.63 5/14/20214,110,000 shares $880.98 million -11.2%N/A2.5 $214.35 4/30/20214,630,000 shares $980.91 million -5.3%N/A2.5 $211.86 4/15/20214,890,000 shares $1.06 billion +15.1%N/A2.4 $217.13 3/31/20214,250,000 shares $905.21 million -14.7%N/A2.1 $212.99 3/15/20214,980,000 shares $1.07 billion +14.5%N/A2.5 $214.33 2/26/20214,350,000 shares $926.46 million +9.0%N/A2.2 $212.98 2/12/20213,990,000 shares $839.88 million +15.0%N/A2 $210.50 1/29/20213,470,000 shares $798.24 million +5.5%N/A1.8 $230.04 1/15/20213,290,000 shares $743.93 million -2.4%N/A1.8 $226.12 12/31/20203,370,000 shares $784.13 million +3.7%N/A1.6 $232.68 12/15/20203,250,000 shares $741.42 million +21.3%N/A1.5 $228.13 11/30/20202,680,000 shares $607.58 million -2.6%N/A1.3 $226.71 10/30/20202,920,000 shares $604.47 million -7.6%N/A1.6 $207.01 10/15/20203,160,000 shares $857.81 million -6.8%N/A1.9 $271.46 9/30/20203,390,000 shares $922.49 million +11.5%N/A2.7 $272.12 9/15/20203,040,000 shares $811.22 million -9.3%N/A2.3 $266.85 8/31/20203,350,000 shares $935.05 million +4.0%N/A2.4 $279.12Gold Prices Surge and This $0.32 Stock Is Reaping The Rewards (Ad)Gold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially for a $0.32 gold producer that's flying under the radar.Here's what you need to know about this $0.32 gold producer. 8/14/20203,220,000 shares $860.67 million -4.2%N/A2 $267.29 7/31/20203,360,000 shares $913.92 million -17.0%N/A2 $272.00 7/15/20204,050,000 shares $1.19 billion -6.5%N/A2.2 $293.83 6/30/20204,330,000 shares $1.26 billion +2.9%N/A2.2 $290.31 6/15/20204,210,000 shares $1.13 billion +7.7%N/A2 $267.77 5/29/20203,910,000 shares $1.08 billion -1.5%N/A1.7 $277.38 5/15/20203,970,000 shares $1.15 billion +2.6%N/A1.8 $288.69 4/30/20203,870,000 shares $972.14 million +13.2%N/A1.8 $251.20 4/15/20203,420,000 shares $872.89 million -14.9%N/A1.7 $255.23 3/31/20204,020,000 shares $956.56 million +29.4%N/A2.1 $237.95 3/13/20203,107,300 shares $766.29 million +7.9%N/A1.6 $246.61 2/28/20202,880,000 shares $582.36 million +9.5%N/A2 $202.21 2/14/20202,630,000 shares $606.24 million -16.2%N/A1.9 $230.51 1/31/20203,140,000 shares $728.61 million -11.6%N/A2.4 $232.04 1/15/20203,550,000 shares $879.73 million -1.1%N/A2.7 $247.81 12/31/20193,590,000 shares $822.33 million -0.8%N/A2.7 $229.06 VRTX Short Interest - Frequently Asked Questions What is Vertex Pharmaceuticals' current short interest? Short interest is the volume of Vertex Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 4,350,000 shares of VRTX short. 1.69% of Vertex Pharmaceuticals' shares are currently sold short. Learn More on Vertex Pharmaceuticals' current short interest. What is a good short interest ratio for Vertex Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VRTX shares currently have a short interest ratio of 4.0. Learn More on Vertex Pharmaceuticals's short interest ratio. Which institutional investors are shorting Vertex Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Vertex Pharmaceuticals: Walleye Trading LLC, Jane Street Group LLC, Kynam Capital Management LP, Torno Capital LLC, PEAK6 Investments LLC, JPMorgan Chase & Co., Twin Tree Management LP, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., Simplex Trading LLC, and Nomura Holdings Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Vertex Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.69% of Vertex Pharmaceuticals' floating shares are currently sold short. Is Vertex Pharmaceuticals' short interest increasing or decreasing? Vertex Pharmaceuticals saw a increase in short interest in May. As of May 31st, there was short interest totaling 4,350,000 shares, an increase of 15.4% from the previous total of 3,770,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vertex Pharmaceuticals' float size? Vertex Pharmaceuticals currently has issued a total of 258,050,000 shares. Some of Vertex Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vertex Pharmaceuticals currently has a public float of 257,360,000 shares. How does Vertex Pharmaceuticals' short interest compare to its competitors? 1.69% of Vertex Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies compare to Vertex Pharmaceuticals: Amgen Inc. (1.69%), Regeneron Pharmaceuticals, Inc. (1.59%), Gilead Sciences, Inc. (2.05%), Biogen Inc. (2.09%), Alnylam Pharmaceuticals, Inc. (1.96%), Royalty Pharma plc (3.45%), BioMarin Pharmaceutical Inc. (1.60%), BeiGene, Ltd. (1.63%), Neurocrine Biosciences, Inc. (2.12%), Incyte Co. (5.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short Vertex Pharmaceuticals stock? Short selling VRTX is an investing strategy that aims to generate trading profit from Vertex Pharmaceuticals as its price is falling. VRTX shares are trading down $5.74 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vertex Pharmaceuticals? A short squeeze for Vertex Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VRTX, which in turn drives the price of the stock up even further. How often is Vertex Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRTX, twice per month. The most recent reporting period available is May, 31 2024. More Short Interest Resources from MarketBeat Related Companies: AMGN Short Squeeze REGN Short Squeeze GILD Short Squeeze BIIB Short Squeeze ALNY Short Squeeze RPRX Short Squeeze BMRN Short Squeeze BGNE Short Squeeze NBIX Short Squeeze INCY Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VRTX) was last updated on 6/13/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of ne...Chaikin Analytics | SponsoredGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredWall Street Icon: "I'd Put 50% of My Kids' Inheritance in THIS stock"Wall Street Icon Warns: "A Great Financial Reset is Underway" The man CNBC called "The Prophet" predicted t...Stansberry Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.